MedTrace Logo

The Effect of Heparinization Due to LBW

NCT03113708 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2017-04-14

No results posted yet for this study

Summary

High dose heparin regimens are required in cardiac surgery under cardiopulmonary bypass (CPB) and this may increase postoperative bleeding. The aim of this study is to evaluate the effect of heparin dose calculated according to lean body weight on intraoperative and postoperative bleeding.

Conditions

Interventions

DRUG

Heparin Sodium

Heparinisation 2-4 mg/kg will be done according to actual body weight or lean body weight.

Sponsors & Collaborators

  • Adiyaman University Research Hospital

    lead OTHER

Principal Investigators

  • Ulku Sabuncu · Yuksek Ihtisas Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-30
Primary Completion
2017-05-20
Completion
2017-06-20

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03113708 on ClinicalTrials.gov